XML 38 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Equity - USD ($)
Amount ($0.12 par)
Subscription Receivable
Additional Paid-in Capital
Legal Reserve
Warrants Reserves
Accumulated Other Comprehensive Income
Retained earnings (Deficit)
Non- controlling Interests
Total
Balance at Dec. 31, 2021 $ 63,606 $ (50,000) $ 15,379,595 $ 223,500 $ 251,036 $ 821,527 $ (10,204,220) $ 39,935 $ 6,524,979
Balance (in Shares) at Dec. 31, 2021 [1] 529,766                
Net loss [2],[3]                 (18,666,058)
Foreign currency translation difference (260,682) (260,682)
Stock-based compensation $ 840 251,255 252,095
Stock-based compensation (in Shares) [1] 7,000                
Cancellation of shares
Cancellation of shares (in Shares) [1] (2)                
Remeasurements of defined benefit plan 551,649 551,649
Issuance of ordinary shares through private placements $ 49,978 18,225,750 18,275,728
Issuance of ordinary shares through private placements (in Shares) [1] 416,483                
Issuance of ordinary shares through exercise of warrants $ 32,960 2,981,751 3,014,711
Issuance of ordinary shares through exercise of warrants (in Shares) [1] 274,659                
Issuance of ordinary shares for acquisition of subsidiaries $ 17,769 4,562,111 4,579,880
Issuance of ordinary shares for acquisition of subsidiaries (in Shares) [1] 148,071                
Issuance of ordinary shares for deposit paid for subsequently terminated acquisitions of subsidiaries subsequently terminated $ 29,160 4,830,840 4,860,000
Issuance of ordinary shares for deposit paid for subsequently terminated acquisitions of subsidiaries subsequently terminated (in Shares) [1] 243,000                
Net loss for the year end from continuing operations (18,549,500) (54,126) (18,603,626) [2],[3]
Net loss for the year end from discontinued operations (15,294) (47,138) (62,432) [2],[3]
Balance at Dec. 31, 2022 $ 194,313 (50,000) 46,231,302 223,500 251,036 1,112,494 (28,769,014) (61,329) 19,132,302
Balance (in Shares) at Dec. 31, 2022 [1] 1,618,977                
Net loss                 (29,589,382)
Foreign currency translation difference (130,860) (130,860)
Stock-based compensation 271,800 271,800
Cancellation of shares $ (29,441) (4,880,223) (4,909,664)
Cancellation of shares (in Shares) 245,339                
Issuance of ordinary shares through CMPOs $ 593,542 20,273,844 20,867,386
Issuance of ordinary shares through CMPOs (in Shares) 4,946,184                
Remeasurements of defined benefit plan 3,486 3,486
Issuance of ordinary shares through exercise of warrants $ 15,468 491,224 506,692
Issuance of ordinary shares through exercise of warrants (in Shares) 128,901                
Issuance of ordinary shares for acquisition of assets $ 31,500 1,816,500 1,848,000
Issuance of ordinary shares for acquisition of assets (in Shares) 262,500                
Issuance of ordinary shares for a convertible note conversion $ 20,640 1,217,760 1,238,400
Issuance of ordinary shares for a convertible note conversion (in Shares) 172,000                
Issuance of ordinary shares for a borrowing conversion $ 353,658 15,560,957 15,914,615
Issuance of ordinary shares for a borrowing conversion (in Shares) 2,947,150                
Net loss for the year end from continuing operations (29,594,240) (29,280) (29,623,520)
Net loss for the year end from discontinued operations 22,579 11,559 34,138
Balance at Dec. 31, 2023 $ 1,179,680 (50,000) 80,983,164 223,500 251,036 985,120 (58,340,675) (79,050) $ 25,152,775
Balance (in Shares) at Dec. 31, 2023 9,830,373               9,830,373 [4]
Disposal of a subsidiary $ (131) (2,651) (974) $ (3,756)
Disposal of a subsidiary (in Shares) (1,091)                
Issuance of ordinary shares through At the Market Offering $ 900,266 9,499,466 10,399,732
Issuance of ordinary shares through At the Market Offering (in Shares) 7,502,220                
Net loss (5,864,165) 19,465 (5,844,700)
Foreign currency translation difference (122,561) (122,561)
Stock-based compensation $ 57,293 2,622,063 2,679,356
Stock-based compensation (in Shares) 477,445                
Remeasurements of defined benefit plan           (271,578)     (271,578)
Net loss for the year end from continuing operations                 (5,883,419)
Net loss for the year end from discontinued operations                 38,719
Balance at Dec. 31, 2024 $ 2,137,108 $ (50,000) $ 93,102,042 $ 223,500 $ 251,036 $ 590,981 $ (64,204,840) $ (60,559) $ 31,989,268
Balance (in Shares) at Dec. 31, 2024 17,808,947               17,808,947 [4]
[1] Giving retroactive effect to the 2023 share consolidation on January 31, 2023, the outstanding ordinary shares of a par value is automatically converted.
[2] Certain amounts have been restated to reflect the reclassification adjustments made between continuing operations and discontinued operations related to the divestiture of Handshake (Note 27).
[3] Certain amounts have been restated to reflect the reclassification adjustments made between continuing operations and discontinued operations related to the divestiture of Handshake for fiscal year ended December 31, 2022 (Note 27).
[4] Giving retroactive effect to the 2023 share consolidation on January 31, 2023.